HLS Therapeutics Inc (74D) Ownership - Who Owns HLS Therapeutics Inc?
HLS Therapeutics Inc (74D) Ownership Overview
- 0.11% Insiders
- 0.01% Mutual Funds
- 1.61% Other Institutional Investors
- 0.02% ETFs
- 98.25% Public Companies and Individual Investors
The ownership structure of HLS Therapeutics Inc (DE:74D) stock is a mix of institutional, retail, and individual investors. Approximately 1.65% of the company’s stock is owned by Institutional Investors, 0.11% is owned by Insiders, and 98.25% is owned by Public Companies and Individual Investors.
The ownership structure of HLS Therapeutics Inc (DE:74D) stock is a mix of institutional, retail, and individual investors. Approximately 1.65% of the company’s stock is owned by Institutional Investors, 0.11% is owned by Insiders, and 98.25% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 08, 2026 | John Gordon Hanna | C$7,456 | |
| Sep 08, 2026 | Ryan Christopher Lennox | C$7,660 | |
| Aug 24, 2026 | Craig Millian | $1,365 | |
| Aug 18, 2026 | Craig Millian | $5,580 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Craig Millian | 17,000 | Insider | 0.05% | 52,955 |
| John Gordon Hanna | 14,000 | Insider | 0.05% | 43,610 |
| Dimensional | 5,967 | Institution | 0.02% | 18,587 |
| Sei Institutional Investments Trust | 2,600 | Institution | <0.01% | 8,099 |
| Ryan Christopher Lennox | 2,500 | Insider | <0.01% | 7,788 |
| Dfa Investment Dimensions Group Inc | 1,000 | Institution | <0.01% | 3,115 |
| John Hancock Variable Insurance Trust | 700 | Institution | <0.01% | 2,181 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Sei Institutional Investments Trust | 2,600 | Institution | <0.01% | 8,099 |
| Dfa Investment Dimensions Group Inc | 1,000 | Institution | <0.01% | 3,115 |
| John Hancock Variable Insurance Trust | 700 | Institution | <0.01% | 2,181 |
FAQ
Who Owns HLS Therapeutics Inc (DE:74D)?
According to the latest TipRanks data, approximately 1.65% of the company's stock is held by institutional investors, 0.11% is held by insiders, and 98.25% is held by public companies and individual investors.
What percentage of HLS Therapeutics Inc (DE:74D) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.65% of HLS Therapeutics Inc (DE:74D) stock is held by institutional investors: 0.01% by mutual funds, 0.02% by ETFs and 1.61% by other institutional investors.
What percentage of HLS Therapeutics Inc (DE:74D) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.25% of HLS Therapeutics Inc (DE:74D) stock is held by public companies and individual investors.
Who owns the most shares of HLS Therapeutics Inc (DE:74D)?
Craig Millian owns the most shares of HLS Therapeutics Inc (DE:74D).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.